Value Investing
If you’re looking at equities, NSE leads, but BSE offers niche opportunities. For commodities, MCX is the top choice, while NeML is revolutionizing rural markets with digital solutions.
Interestingly, more than half of the orders L&T received in the December quarter originated from the Middle East, underscoring the region’s increasing importance to L&T’s business. However, the company is also cautious about potential cost implications due to logistic disruptions in the Red Sea, which have affected shipping routes, particularly the Suez Canal. The company is exploring alternative routes to mitigate these risks. Despite the anticipation of subdued order activity in the upcoming quarters due to India’s general elections, L&T has a robust domestic order backlog and expects to maintain its momentum in international markets.
Furthermore, L&T Construction’s Buildings & Factories Business has secured a significant order from HITES under the Ministry of Health and Family Welfare to construct a new AIIMS in Rewari, Haryana. This project emphasizes L&T’s capability in executing large-scale infrastructure projects within stringent timelines
Navayuga Engineering has recently been in the news for several significant developments and incidents:
If you’re looking at equities, NSE leads, but BSE offers niche opportunities. For commodities, MCX is the top choice, while NeML is revolutionizing rural markets with digital solutions.
Mastek, Persistent Systems, KPIT, and Mphasis cater to different IT segments. KPIT leads in automotive software (high growth, expensive valuation). Persistent is strong in digital transformation, Mphasis in BFSI, and Mastek in cloud ERP (UK-focused). Persistent offers a balance of growth and valuation, while KPIT has industry tailwinds.
Kaveri Seeds, UPL, Bayer CropScience, and Rasi Seeds are key players in India’s agribusiness sector. Kaveri and Rasi dominate hybrid seeds, while UPL leads agrochemicals. Bayer excels in biotech but faces regulatory hurdles. UPL offers high growth but carries debt, while Kaveri and Bayer provide stable investment potential.